Piper Sandler initiated coverage of Enfusion with a Neutral rating and $11 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ENFN:
Piper Sandler initiated coverage of Enfusion with a Neutral rating and $11 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ENFN: